GE HealthCare (GEHC) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
GE HealthCare (GEHC) PT Raised to $91 at BTIG
February 4, 2026 12:33 PM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $91.00 (from $87.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $91 (from $87) following 4Q25 results. Order growth came in at ~2.0% with a Book-to-Bill ratio of 1.06x off a more challenging... More
